


Healthcare Industry NewsFeed
HSMN NewsFeed - 15 Jan 2015
Seres Health Appoints Shelley Trucksis, Ph.D., M.D. as Executive Vice President and Chief Medical Officer
Seres Health Appoints Shelley Trucksis, Ph.D., M.D. as Executive Vice President and Chief Medical Officer
HSMN NewsFeed - 13 Jan 2015
Teleflex Awarded HealthTrust Agreement for Peripherally Inserted Central Catheter (PICC) Products
Teleflex Awarded HealthTrust Agreement for Peripherally Inserted Central Catheter (PICC) Products
HSMN NewsFeed - 13 Jan 2015
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
HSMN NewsFeed - 12 Jan 2015
CTI BioPharma Appoints Alan K. Burnett, M.D. As Therapeutic Area Lead, Myeloid Diseases
CTI BioPharma Appoints Alan K. Burnett, M.D. As Therapeutic Area Lead, Myeloid Diseases
HSMN NewsFeed - 9 Jan 2015
Micro Interventional Devices, Inc. Completes STASIS Clinical Trial Enrollment
Micro Interventional Devices, Inc. Completes STASIS Clinical Trial Enrollment
HSMN NewsFeed - 8 Jan 2015
Straub Medical AG obtains approval for Rotarex(R)S and Aspirex(R)S endovascular catheters in China
Straub Medical AG obtains approval for Rotarex(R)S and Aspirex(R)S endovascular catheters in China
HSMN NewsFeed - 7 Jan 2015
Philips receives FDA 510(k) clearance for its latest Avalon CL Fetal Monitoring solution
Philips receives FDA 510(k) clearance for its latest Avalon CL Fetal Monitoring solution
HSMN NewsFeed - 6 Jan 2015
CytomX Raises $20 Million in Series C Round Led by Pfizer Venture Investments
CytomX Raises $20 Million in Series C Round Led by Pfizer Venture Investments
HSMN NewsFeed - 6 Jan 2015
Cohera Medical, Inc.(R) Receives PMA Approvable Letter from U.S. FDA for TissuGlu(R) Surgical Adhesive
Cohera Medical, Inc.(R) Receives PMA Approvable Letter from U.S. FDA for TissuGlu(R) Surgical Adhesive
HSMN NewsFeed - 6 Jan 2015
CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results in Glioblastoma Multiforme (Brain Cancer)
CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results in Glioblastoma Multiforme (Brain Cancer)
HSMN NewsFeed - 5 Jan 2015
Catalyst Pharmaceuticals Appoints David D. Muth, Executive Vice President, Chief Commercial Officer
Catalyst Pharmaceuticals Appoints David D. Muth, Executive Vice President, Chief Commercial Officer
